A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen.

癌胚抗原 医学 抗原 树突状细胞 外周血单个核细胞 免疫疗法 免疫学 免疫系统 体外 内科学 生物 癌症 生物化学
作者
Michael A. Morse,Yuping Deng,Daniel Coleman,Shelley Hull,E. Kitrell-Fisher,Smita K. Nair,Jeffrey Schlom,Mary Ellen Ryback,H. Kim Lyerly
出处
期刊:PubMed 卷期号:5 (6): 1331-8 被引量:297
链接
标识
摘要

Dendritic cells (DCs), antigen-presenting cells capable of priming naive T cells to specific antigens in an HLA-restricted fashion, have been demonstrated to induce protective T cell-mediated immunity in tumor-bearing animals. We performed this study to test the safety, feasibility, and clinical response of immunizations with in vitro-generated DCs, loaded with an HLA-A2-restricted peptide fragment of the tumor antigen carcinoembryonic antigen (CEA), for the treatment of patients with advanced CEA-expressing malignancies. Cell preparations enriched for autologous DCs were generated from the patients' plastic adherent peripheral blood mononuclear cells in serum-free media supplemented with granulocyte macrophage colony-stimulating factor and interleukin-4. Within the cell preparation, 66% of the cells expressed the phenotype typical for DCs (CD86high, HLA-DRhigh, and CD14low). The DCs were loaded with the CEA peptide CAP-1 and cryopreserved. Groups of three to six patients received four weekly or biweekly i.v. infusions of the CAP-1-loaded DC in escalating dose levels of 1 x 10(7), 3 x 10(7), and 1 x 10(8) cells/dose. A subset of the patients in the last group also received intradermal injections of 1 x 10(6) DCs. There were no toxicities directly referable to the treatments. One patient had a minor response, and one had stable disease. Skin punch biopsy at DC injection sites demonstrated pleomorphic infiltrates in the three patients evaluated. We conclude that it is feasible and safe to generate and administer large numbers of previously cryopreserved DCs loaded with CAP-1 peptide to patients with advanced malignancies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
芮rich完成签到,获得积分10
1秒前
科研通AI2S应助12544593556采纳,获得10
2秒前
3秒前
4秒前
丘比特应助娄医生采纳,获得10
4秒前
思源应助IF采纳,获得10
7秒前
8秒前
8秒前
李李发布了新的文献求助10
9秒前
iamdnn完成签到,获得积分10
10秒前
呢呢发布了新的文献求助20
11秒前
12秒前
知来者之可追完成签到,获得积分10
13秒前
14秒前
单薄的雪旋完成签到,获得积分10
14秒前
田乐天完成签到 ,获得积分10
14秒前
15秒前
iamdnn发布了新的文献求助10
16秒前
tongxiehou1完成签到,获得积分10
17秒前
IF完成签到,获得积分20
19秒前
啊啊啊啊啊完成签到,获得积分10
19秒前
领导范儿应助吾身无拘采纳,获得10
19秒前
20秒前
哈哈应助忧心的从阳采纳,获得10
20秒前
皮老姆完成签到,获得积分10
21秒前
tongxiehou1发布了新的文献求助10
21秒前
Fen发布了新的文献求助80
22秒前
24秒前
25秒前
binyh发布了新的文献求助10
25秒前
25秒前
深情安青应助怕黑紫伊采纳,获得10
26秒前
Lin发布了新的文献求助10
27秒前
cookie完成签到,获得积分10
27秒前
27秒前
chenshiyi185发布了新的文献求助10
28秒前
nan完成签到,获得积分10
32秒前
32秒前
33秒前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3161200
求助须知:如何正确求助?哪些是违规求助? 2812600
关于积分的说明 7895715
捐赠科研通 2471437
什么是DOI,文献DOI怎么找? 1316018
科研通“疑难数据库(出版商)”最低求助积分说明 631074
版权声明 602112